# SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort

> **NCT05067400** · — · COMPLETED · sponsor: **Royal Free Hospital NHS Foundation Trust** · enrollment: 615 (actual)

## Conditions studied

- HIV-1-infection
- SARS-CoV Infection
- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05067400
- **Lead sponsor:** Royal Free Hospital NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-21
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 615 (ACTUAL)
- **Last updated:** 2023-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05067400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05067400, "SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05067400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*